The Global Gunshot
Injuries Treatment Market was valued at US$ 6.9 million in 2015 and is
projected to exhibit a CAGR of 8.2% over the forecast period (2017–2025).
Technological developments such as innovative pocket sized device, which use
tiny sponges and emergency treatment in the battlefield for soldiers, are
expected to be major factors driving growth of the global gunshot injuries
treatment market over the foreseeable future. Efficient treatment by products
that prevent postpartum hemorrhage to boost the gunshot injuries treatment
market Postpartum hemorrhage (PPH) is the leading cause of maternal mortality
in low-income countries, and responsible for a quarter of all maternal deaths
globally.
According to an article published
by Medscape, pregnancy-related mortality ratio was estimated to be 17.3 deaths
per 100,000 pregnant women, with around 11.4% of these deaths caused due by
postpartum hemorrhage, in 2013. The initiatives taken by organizations such as
the United States Agency for International Development (USAID), the Government
of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada,
and the UK Government to aid research for the development of preventive devices
for PPH is a major factor causing expansion of the gunshot injuries treatment
market.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/772
Furthermore, the development of
the XSTAT-PPH device by Oregon Health & Science Univsersity and RevMedx for
the treatment of postpartum hemorrhage (PPH) in low resource settings
accelerates growth of the gunshot injuries treatment market.
Surgical priorities for
prevention of gunshot management includes hemorrhage control, prevention, and
reconstruction of infection, as gunshot has potential to damage affected
tissues. The Xstat syringe was the only FDA-approved device for immediate
treatment of blood flow. According to an article published in Current Reviews
in Musculoskeletal Medicine, in 2015, around 70% of battlefield wounds
sustained in conflict since the Second World War were gunshot injuries during
the early phases of conflicts. Furthermore, affected soldiers require immediate
transfer to trauma center for definitive management for conducting initial care
and stabilization in emergency department.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/gunshot-injuries-treatment-market-772
Key takeaways of the Gunshot
Injuries Treatment Market:
The global gunshot injuries
treatment market is expected to exhibit a CAGR of 8.2% over the forecast
period, with economies in Asia Pacific, Latin America, Middle East, and Africa
focusing on increasing their military spending.
The Xstat is the dominant product
segment in the market, as this portable device provides emergency treatment for
soldiers in the battlefield
RevMedx, Inc currently is the
only player involved in the global gunshot injuries treatment market.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/772
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment